ZA961897B - 6,7-substituted-2-aminotetralines and use thereof - Google Patents

6,7-substituted-2-aminotetralines and use thereof

Info

Publication number
ZA961897B
ZA961897B ZA961897A ZA961897A ZA961897B ZA 961897 B ZA961897 B ZA 961897B ZA 961897 A ZA961897 A ZA 961897A ZA 961897 A ZA961897 A ZA 961897A ZA 961897 B ZA961897 B ZA 961897B
Authority
ZA
South Africa
Prior art keywords
aminotetralines
substituted
methoxytetraline
antiinflammatory
fluoro
Prior art date
Application number
ZA961897A
Other languages
English (en)
Inventor
Piero Foresta
Vito Ruggiero
Original Assignee
Sigma Tau Ind Farmaceuti
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sigma Tau Ind Farmaceuti filed Critical Sigma Tau Ind Farmaceuti
Publication of ZA961897B publication Critical patent/ZA961897B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/222—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin with compounds having aromatic groups, e.g. dipivefrine, ibopamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pain & Pain Management (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Engineering & Computer Science (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
ZA961897A 1995-03-09 1996-03-08 6,7-substituted-2-aminotetralines and use thereof ZA961897B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT95RM000143A IT1278045B1 (it) 1995-03-09 1995-03-09 Uso di 2-amminotetraline-6,7-sostituite per la preparazione di composizioni farmaceutiche atte al trattamento dello shock, e di

Publications (1)

Publication Number Publication Date
ZA961897B true ZA961897B (en) 1996-09-12

Family

ID=11403118

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA961897A ZA961897B (en) 1995-03-09 1996-03-08 6,7-substituted-2-aminotetralines and use thereof

Country Status (14)

Country Link
US (1) US5591777A (pt)
EP (1) EP0730861B1 (pt)
JP (1) JPH08268884A (pt)
KR (1) KR100286141B1 (pt)
AT (1) ATE195072T1 (pt)
CA (1) CA2171081A1 (pt)
DE (1) DE69609541T2 (pt)
DK (1) DK0730861T3 (pt)
ES (1) ES2150034T3 (pt)
GR (1) GR3034688T3 (pt)
IT (1) IT1278045B1 (pt)
PT (1) PT730861E (pt)
TW (1) TW471967B (pt)
ZA (1) ZA961897B (pt)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1290910B1 (it) * 1997-02-03 1998-12-14 Sigma Tau Ind Farmaceuti 2-amminotetralina otticamente attiva, procedimento per la sua preparazione e composizioni farmaceutiche che la contengono, attive
IT1294932B1 (it) * 1997-09-22 1999-04-23 Sigma Tau Ind Farmaceuti Uso di 2-amminotetraline-6,7 sostituite per la preparazione di composizioni farmaceutiche atte al trattamento di patologie
IT1294931B1 (it) * 1997-09-22 1999-04-23 Sigma Tau Ind Farmaceuti Derivati della 2-amminotetralina procedimento per la loro preparazione e composizioni farmaceutiche che li contengono, attive nella
US7125904B2 (en) 2002-10-11 2006-10-24 Portela & C.A., S.A. Peripherally-selective inhibitors of dopamine-β-hydroxylase and method of their preparation

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1199339B (it) * 1986-12-23 1988-12-30 Sigma Tau Ind Farmaceuti N-alchil derivati della 2-ammino-6,7-dimetossi tetralina,procedimenti per la loro preparazione e composizioni farmaceutiche ad attivita'an tiipertensiva che li contengono
SE8904127D0 (sv) * 1989-12-07 1989-12-07 Astra Ab New biocyclic amino-substituted compounds
IT1241988B (it) * 1990-06-15 1994-02-02 Sigma Tau Ind Farmaceuti 2- amminotetraline-6, 7-sostituite attive come immunomodulanti e composizioni farmaceutiche che le contengono

Also Published As

Publication number Publication date
EP0730861B1 (en) 2000-08-02
IT1278045B1 (it) 1997-11-17
GR3034688T3 (en) 2001-01-31
DE69609541D1 (de) 2000-09-07
ITRM950143A1 (it) 1996-09-09
JPH08268884A (ja) 1996-10-15
ITRM950143A0 (it) 1995-03-09
TW471967B (en) 2002-01-11
US5591777A (en) 1997-01-07
ATE195072T1 (de) 2000-08-15
DK0730861T3 (da) 2000-10-09
EP0730861A1 (en) 1996-09-11
CA2171081A1 (en) 1996-09-10
KR100286141B1 (ko) 2001-04-16
KR960033450A (ko) 1996-10-22
DE69609541T2 (de) 2000-12-21
ES2150034T3 (es) 2000-11-16
PT730861E (pt) 2000-11-30

Similar Documents

Publication Publication Date Title
NO990542L (no) K-252a-derivater og anvendelse av K-252a-derivater
ZA9510727B (en) 2-¬(Dihydro) pyrazol-3'-yloxymethylene¾ anilides their preparation and their use
CA2207323A1 (en) Use of pramipexole as a neuroprotective agent
GR1002038B (en) Laparascopic instrument for the application of endoligatures.
MX9704030A (es) 1,1-dioxidos de 2-heterocicliloxi y tiometil-1,2,5-tiadiazolidin-3-ona y composiciones y metodo de uso de los mismos.
IL110204A0 (en) Novel indolene derivatives, processes for their preparation and their use for the treatment of cns disorders
AU4329396A (en) Use of 3,4-diphenylchromans
FR2716881B1 (fr) Procédé de préparation et de purification d'Iopamidol.
FI941776A0 (fi) Menetelmä 1,2,4-tiadiatsolien valmistamiseksi
FR2720070B1 (fr) Procédé de préparation d'alkylpolysiloxanes pontés et alkylpolysiloxanes pontés.
MX9704034A (es) Derivados y composiciones de 1,1-dioxido de 2-arilcarboniloximetil-1,2,5-tiadiazolidin-3-ona substituido y metodo de uso.
KR970000398B1 (en) Process for the preparation of 1,1,1,2-tetrafluoro-2-chloroethan and pentafluorethane
AU630815B1 (en) New process for the industrial preparation of 4-chloro-3-sulfamoyl-n-(2,3-dihydro-2-methyl-1h-indol-1-yl) benzamide
FR2708266B1 (fr) Procédé de préparation d'alcanesulfonamides.
IT1271567B (it) Procedimento per l'ulteriore trattamento di salcicce
ZA961897B (en) 6,7-substituted-2-aminotetralines and use thereof
NO973366L (no) Fremgangsmåte for behandling av multippel sklerose
TW330933B (en) Furanoeremophilane and eremophilanolide sesquiterpenes for treatment of diabetes
ITRM910146U1 (it) Strumento chirurgico per l'introduzione di protesi peniene.
UA29461C2 (uk) Засіб для лікування амілоїдозу, спосіб лікування амілоїдозу
AU638829B2 (en) Composition for disinfecting water by the electrochlorination process and use of this composition
ITMI913466A0 (it) Procedimento per la depurazione dell'1.1.1-trifluoro-2-fluoroetano e dell'1.1.1-trifuoro-2,2-diocloroetano
TW239124B (en) Process for the preparation of 2,4,5-tribromopyrrole-3-carbonitrile
AU6836694A (en) Purification of 1,1,2-trichloroethane
AU8819691A (en) Treatment of gas